Vikram Roongta

Vikram Roongta is currently the Director of GLP Bioanalysis at Absorption Systems, where they manage the development and validation of bioanalytical methods for clinical studies. Previously, they served as the Laboratory Director at NorthEast Bioanalytical Laboratories and held multiple senior scientific roles at Bristol-Myers Squibb, contributing to significant drug approvals including the SGLT2 diabetes drug, FARXIGA. With extensive expertise in analytical chemistry, Vikram has successfully managed various bioanalytical projects and ensured compliance with regulatory guidelines. Their educational background and professional experience highlight a strong foundation in analytical methods and biochemistry.